Fludarabine
Vulva Cancer
Christian HinrichsSmall moleculePhase 2Active
B
59/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 44/ 100
- Competitive Position
- 89/ 100
Competitive context
5 Active assets in the Vulva Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Indocyanine Green Istanbul University | Phase 4 | BB |
TECHNETIUM-99 Institut de Cancérologie de Lorraine | Phase 3 | B |
e7 tcr-t cells Christian Hinrichs | Phase 2 | B |
Carbon Nanoparticle-Loaded Iron Sichuan Enray Pharmaceutical Sciences Company | Phase 1/2 | CC |
Cnsi-Fe Sichuan Enray Pharmaceutical Sciences Company | Phase 1 | CC |
scg142 tcr-t cells The Affiliated Hospital of Qingdao University | Phase 1 | CC |
Same molecule, other indications
Fludarabine is also rated in:
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →